AGIOS PHARMACEUTICALS, INC. Quarterly Common Stock, Shares, Issued from Q4 2012 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Agios Pharmaceuticals, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2012 to Q2 2024.
  • Agios Pharmaceuticals, Inc. Common Stock, Shares, Issued for the quarter ending June 30, 2024 was 73.1M shares, a 1.59% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 73.1M +1.14M +1.59% Jun 30, 2024 10-Q 2024-08-01
Q1 2024 73M +1.21M +1.69% Mar 31, 2024 10-Q 2024-05-02
Q4 2023 72.2M +905K +1.27% Dec 31, 2023 10-Q 2024-08-01
Q3 2023 72.1M +990K +1.39% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 72M +919K +1.29% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 71.8M +765K +1.08% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 71.3M +705K +1% Dec 31, 2022 10-K 2024-02-15
Q3 2022 71.1M +595K +0.84% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 71M +627K +0.89% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 71M +1.18M +1.69% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 70.6M +1.26M +1.81% Dec 31, 2021 10-K 2023-02-23
Q3 2021 70.5M +1.32M +1.9% Sep 30, 2021 10-Q 2021-11-03
Q2 2021 70.4M +1.35M +1.95% Jun 30, 2021 10-Q 2021-07-29
Q1 2021 69.8M +1.02M +1.49% Mar 31, 2021 10-Q 2021-04-29
Q4 2020 69.3M +893K +1.31% Dec 31, 2020 10-K 2022-02-24
Q3 2020 69.2M +10.3M +17.5% Sep 30, 2020 10-Q 2020-11-05
Q2 2020 69.1M +10.3M +17.5% Jun 30, 2020 10-Q 2020-07-30
Q1 2020 68.8M +10.1M +17.3% Mar 31, 2020 10-Q 2020-04-30
Q4 2019 68.4M +10.2M +17.5% Dec 31, 2019 10-K 2021-02-25
Q3 2019 58.9M +710K +1.22% Sep 30, 2019 10-Q 2019-10-31
Q2 2019 58.7M +817K +1.41% Jun 30, 2019 10-Q 2019-08-01
Q1 2019 58.7M +1.12M +1.94% Mar 31, 2019 10-Q 2019-05-02
Q4 2018 58.2M +9.39M +19.2% Dec 31, 2018 10-K 2020-02-19
Q3 2018 58.2M +9.55M +19.6% Sep 30, 2018 10-Q 2018-11-01
Q2 2018 57.9M +9.59M +19.8% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 57.5M +15.2M +35.8% Mar 31, 2018 10-Q 2018-05-04
Q4 2017 48.8M +6.61M +15.6% Dec 31, 2017 10-K 2019-02-14
Q3 2017 48.6M +6.6M +15.7% Sep 30, 2017 10-Q 2017-11-01
Q2 2017 48.3M +10.3M +27.1% Jun 30, 2017 10-Q 2017-08-08
Q1 2017 42.4M +4.48M +11.8% Mar 31, 2017 10-Q 2017-05-04
Q4 2016 42.2M +4.52M +12% Dec 31, 2016 10-K 2018-02-14
Q3 2016 42M +4.41M +11.7% Sep 30, 2016 10-Q 2016-11-03
Q2 2016 38M +628K +1.68% Jun 30, 2016 10-Q 2016-08-08
Q1 2016 37.9M +610K +1.64% Mar 31, 2016 10-Q 2016-05-09
Q4 2015 37.7M +596K +1.61% Dec 31, 2015 10-K 2017-02-16
Q3 2015 37.6M +2.96M +8.55% Sep 30, 2015 10-Q 2015-11-06
Q2 2015 37.4M +2.98M +8.65% Jun 30, 2015 10-Q 2015-08-07
Q1 2015 37.3M +5.46M +17.1% Mar 31, 2015 10-Q 2015-05-11
Q4 2014 37.1M +5.9M +18.9% Dec 31, 2014 10-K 2016-02-26
Q3 2014 34.6M +3.57M +11.5% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 34.4M +30.7M +813% Jun 30, 2014 10-Q 2014-08-07
Q1 2014 31.8M Mar 31, 2014 10-Q 2014-05-09
Q4 2013 31.2M +27.6M +763% Dec 31, 2013 10-K 2015-02-24
Q3 2013 31.1M Sep 30, 2013 10-Q 2013-11-07
Q2 2013 3.77M Jun 30, 2013 10-Q 2013-09-05
Q4 2012 3.62M Dec 31, 2012 10-K 2014-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.